PALISADE Follow-on Study (ARC004)
a study on Peanut Allergy
Peanut Allergy AR101 Characterized Peanut Allergen CPNA (Characterized Peanut Allergen) OIT (oral immunotherapy) Allergy Peanut-Allergic Children Peanut-Allergic Adults Desensitization PALISADE Hypersensitivity Peanut Hypersensitivity
Lead Scientist at UCSF
- Morna Dorsey
1. Optimizing diagnosis and care of patients with primary immunodeficiency 2. Investigating the psychosocial impact of primary immunodeficiency on patients and families 3. Establishing treatment for patients with food allergy and eosinophilic disorders
- in progress, not accepting new patients
- Start Date
- Completion Date
- Aimmune Therapeutics, Inc.
- Click to request more information about this study.
- Phase 3
- Study Type
- Last Updated